academic article

• Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study..  Lancet.  391:1263-1273. 2018
• The primary care extension program: a catalyst for change. 2013
• Baseline neurocognitive deficits in the CATIE schizophrenia trial..  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.  31:2033-2046. 2006